Analysis of S-1 Venture and impact to HHSE; HHSE has been contacted by multiple venture capital partners, investors and funds expressing their support of buying significant positions into HHSE following the filing for the Form 10 and S-1. There is a total of USD $8-mm potentially available to the company under the S-1 offering, through block offerings of new issues at $.03, $.05 and $.08 per share. A modest "test" of HHSE pricing resistance occurred last July whebn a relatively modest amount of buying pressure about $120,000 (8-mm shares) was conducted last July by one major investor, which buying pressure caused the HHSE stock price to literally DOUBLE in only a few days... accordingly, there is a reasonable basis to anticipate that buying pressure of $1.5-mm initially (i.e., 50-mm S-1 shares at $.03 each) would likely result in a much higher PPS than $.03 / share if purchased on the open market. Therefore the S-1 block pricing - which is CURRENTLY a premium to today's market price of shares - is still a much better deal for these major purchasers than if the same dollar volume were run through the open market. Additionally, as is the structure of a S-1 Registration, the net sales proceeds go to the issuer (HHSE) for corporate uses and endeavors... whereas stocks traded on the open market benefit only the direct participants of a particular trade transaction. The second block of S-1 shares is 50-mm at $.05 each, and the third and final block of shares is another 50-mm at $.08 each.
Market Data 
Markets 
.gif)
